Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlotte Steffensen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|June 1, 2021
[Tardive akathisia after long-term metoclopramide treatment]Astrid Johannesson Hjelholt, Charlotte Uggerhøj Andersen, Charlotte Steffensen
Ugeskrift for Laeger|March 18, 2014
[Acromegaly masked by symptomatic hyperprolactinaemia]Jakob Dal, Charlotte Steffensen, Troels K Hansen, et al.
Clinical Epidemiology|October 17, 2012
The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: implementation of a nationwide patient enrollment systemJens Steen Nielsen, Reimar W Thomsen, Charlotte Steffensen, et al.
European Journal of Endocrinology|June 30, 2016
DIAGNOSIS OF ENDOCRINE DISEASE: Prevalence of hypercortisolism in type 2 diabetes patients: a systematic review and meta-analysisCharlotte Steffensen, Alberto M Pereira, Olaf M Dekkers, et al.
Neuroendocrinology|September 11, 2010
Epidemiology of Cushing's syndromeCharlotte Steffensen, Ann Mosegaard Bak, Kristine Zøylner Rubeck, et al.
Endocrine|October 6, 2016
Cushing's syndrome and pregnancy outcomes: a systematic review of published casesFrancisca Caimari, Elena Valassi, Patricia Garbayo, et al.
Clinical Endocrinology|March 31, 2016
Low positive predictive value of midnight salivary cortisol measurement to detect hypercortisolism in type 2 diabetesCharlotte Steffensen, Henrik H Thomsen, Olaf M Dekkers, et al.
Expert Opinion on Therapeutic Targets|July 14, 2011
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetesAnn Mosegaard Bak, Lærke Egefjord, Michael Gejl, et al.
Ugeskrift for Laeger|March 18, 2014
[Dopamin agonist treatment and fibrotic heart valve disease in hyperprolactinaemia patients]Charlotte Steffensen, Merete Lund Mægbæk, Peter Laurberg, et al.
Clinical Epidemiology|October 17, 2012
The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Project: rationale and planned nationwide studies of genetic predictors, physical exercise, and individualized pharmacological treatmentCharlotte Steffensen, Reimar W Thomsen, Allan Vaag, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|June 1, 2021
[Tardive akathisia after long-term metoclopramide treatment]Astrid Johannesson Hjelholt, Charlotte Uggerhøj Andersen, Charlotte Steffensen
Ugeskrift for Laeger|March 18, 2014
[Acromegaly masked by symptomatic hyperprolactinaemia]Jakob Dal, Charlotte Steffensen, Troels K Hansen, et al.
Clinical Epidemiology|October 17, 2012
The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: implementation of a nationwide patient enrollment systemJens Steen Nielsen, Reimar W Thomsen, Charlotte Steffensen, et al.
European Journal of Endocrinology|June 30, 2016
DIAGNOSIS OF ENDOCRINE DISEASE: Prevalence of hypercortisolism in type 2 diabetes patients: a systematic review and meta-analysisCharlotte Steffensen, Alberto M Pereira, Olaf M Dekkers, et al.
Neuroendocrinology|September 11, 2010
Epidemiology of Cushing's syndromeCharlotte Steffensen, Ann Mosegaard Bak, Kristine Zøylner Rubeck, et al.
Endocrine|October 6, 2016
Cushing's syndrome and pregnancy outcomes: a systematic review of published casesFrancisca Caimari, Elena Valassi, Patricia Garbayo, et al.
Clinical Endocrinology|March 31, 2016
Low positive predictive value of midnight salivary cortisol measurement to detect hypercortisolism in type 2 diabetesCharlotte Steffensen, Henrik H Thomsen, Olaf M Dekkers, et al.
Expert Opinion on Therapeutic Targets|July 14, 2011
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetesAnn Mosegaard Bak, Lærke Egefjord, Michael Gejl, et al.
Ugeskrift for Laeger|March 18, 2014
[Dopamin agonist treatment and fibrotic heart valve disease in hyperprolactinaemia patients]Charlotte Steffensen, Merete Lund Mægbæk, Peter Laurberg, et al.
Clinical Epidemiology|October 17, 2012
The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Project: rationale and planned nationwide studies of genetic predictors, physical exercise, and individualized pharmacological treatmentCharlotte Steffensen, Reimar W Thomsen, Allan Vaag, et al.
Pageof 2